Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Helius Medical Technologies Inc’s stock clocked out at $0.62, up 1.47% from its previous closing price of $0.61. In other words, the price has increased by $1.47 from its previous closing price. On the day, 0.87 million shares were traded. HSDT stock price reached its highest trading level at $0.7551 during the session, while it also had its lowest trading level at $0.62.
Ratios:
To gain a deeper understanding of HSDT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.09 and its Current Ratio is at 3.61. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Noble Capital Markets on March 24, 2021, initiated with a Outperform rating and assigned the stock a target price of $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 14 ’23 when ANDREEFF DANE bought 5,000 shares for $8.10 per share. The transaction valued at 40,475 led to the insider holds 16,512 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HSDT now has a Market Capitalization of 2311465 and an Enterprise Value of -4369714. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.63 while its Price-to-Book (P/B) ratio in mrq is 0.60. Its current Enterprise Value per Revenue stands at -7.356 whereas that against EBITDA is 0.369.
Stock Price History:
Over the past 52 weeks, HSDT has reached a high of $9.50, while it has fallen to a 52-week low of $0.37. The 50-Day Moving Average of the stock is 17.41%, while the 200-Day Moving Average is calculated to be -68.92%.
Shares Statistics:
It appears that HSDT traded 457.34K shares on average per day over the past three months and 281150 shares per day over the past ten days. A total of 3.73M shares are outstanding, with a floating share count of 3.67M. Insiders hold about 1.48% of the company’s shares, while institutions hold 2.17% stake in the company. Shares short for HSDT as of 1730332800 were 225384 with a Short Ratio of 0.21, compared to 1727654400 on 59173. Therefore, it implies a Short% of Shares Outstanding of 225384 and a Short% of Float of 6.38.
Earnings Estimates
The current rating of Helius Medical Technologies Inc (HSDT) reflects the combined expertise of 1 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.92, with high estimates of -$0.92 and low estimates of -$0.92.
Analysts are recommending an EPS of between -$5.64 and -$5.64 for the fiscal current year, implying an average EPS of -$5.64. EPS for the following year is -$2.5, with 1.0 analysts recommending between -$2.5 and -$2.5.
Revenue Estimates
In the current quarter, 1 analysts expect revenue to total $100k. It ranges from a high estimate of $100k to a low estimate of $100k. As of the current estimate, Helius Medical Technologies Inc’s year-ago sales were $134kFor the next quarter, 1 analysts are estimating revenue of $100k. There is a high estimate of $100k for the next quarter, whereas the lowest estimate is $100k.
A total of 1 analysts have provided revenue estimates for HSDT’s current fiscal year. The highest revenue estimate was $468k, while the lowest revenue estimate was $468k, resulting in an average revenue estimate of $468k. In the same quarter a year ago, actual revenue was $644kBased on 1 analysts’ estimates, the company’s revenue will be $510k in the next fiscal year. The high estimate is $510k and the low estimate is $510k.
